William Moss

CEO of Seven Bridges Genomics, USA

William Moss is a seasoned executive with a proven track record of leading emerging insurtech and health science technology organizations to achieve long-term operational objectives and corporate valuations that exceed team member, industry and investor expectations. In his time at Seven Bridges, Moss has been instrumental in facilitating the development of the company’s newly honed biopharma corporate strategy. He was ranked #14 in the Healthcare Technology Report’s Top 50 Healthcare CEO’s 2020. Prior to Seven Bridges, Moss led the transformation of companies such as MFX USA, Delphi Technology and AMS/Towerstreet, in various lead executive roles.

14:30 - 15:30

Parallel sessions

Academia session: Biotechnology - How is it shaping our future?

Moderator and chair of the session: Dr. Jelena Begović, Director of Institute of Molecular Genetics and Genetic Engineering (IMGGE) and Full Research Professor

Dr. Charles Ruranga, Director of the African Centre of Excellence in Data Science, Rwanda
Dr. Claudia Vickers, Chief Scientific Officer at Eden Brew, Australia
Kiren Naidoo, CEO of Zdravlje A.D. and Founder of Frontier Pharma, UK
Martin Mössler, Managing Director of Science Park Graz, Austria
Dr. Nataša Skoko, Head of Biotechnology Development Unit at International Centre for Genetic Engineering and Biotechnology, Italy

Business session: Accelerating innovation

Moderator and chair of the session: Prof. Robert C. Wolcott, Co-Founder and Chairman of The World Innovation Network (TWIN) and Adjunct Professor of Innovation at Booth School of Business at University of Chicago & Kellogg School of Management at Northwestern University

Dan Vahdat, CEO of Huma, UK
Gloria Seibert, Founder & CEO at Temedica, Germany
Dr. Milan Obradović, Senior Global Scientific Director Integrated Healthcare Solutions, Global Medical Affairs at Roche, Switzerland
Dr. Ulrich A.K. Betz, Vice President Innovation in Merck, Germany
William Moss, CEO of Seven Bridges Genomics, USA